APA (7th ed.) Citation

G, G., JJ, R., S, U., A, B., A, B., & G, G. (2024). Advances in the management of higher-risk myelodysplastic syndromes: Future prospects. Leukemia & lymphoma, 65(9), 1233. https://doi.org/10.1080/10428194.2024.2344061

Chicago Style (17th ed.) Citation

G, Gener-Ricos, Rodriguez-Sevilla JJ, Urrutia S, Bataller A, Bazinet A, and Garcia-Manero G. "Advances in the Management of Higher-risk Myelodysplastic Syndromes: Future Prospects." Leukemia & Lymphoma 65, no. 9 (2024): 1233. https://doi.org/10.1080/10428194.2024.2344061.

MLA (9th ed.) Citation

G, Gener-Ricos, et al. "Advances in the Management of Higher-risk Myelodysplastic Syndromes: Future Prospects." Leukemia & Lymphoma, vol. 65, no. 9, 2024, p. 1233, https://doi.org/10.1080/10428194.2024.2344061.